1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Diabetes Disease Overview
4.1 What is Diabetes
4.2 Diabetes Diagnosis and Treatment
4.2.1 Diagnosis
4.2.2 Treatment
4.3 Diabetes Complications
5 Factors Driving the Diabetes Market in India
5.1 Increasing Obesity Levels
5.2 Urbanization
5.3 Impact of COVID-19
5.4 India has the Second Largest Diabetes Patient Base in the World
5.5 India Represents One of the Fastest Growing Markets Globally
5.6 Improving Diagnosis and Treatment Rates
6 The Indian Diabetes Epidemiology
6.1 Diabetes Population and Prevalence Rates
6.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
6.3 Population and Prevalence Rates by Region (Urban and Rural)
6.4 Population and Prevalence Rates by Gender
6.5 Population and Prevalence Rates by Age Group
6.6 Diabetes Diagnosis and Drug Treatment Rates
7 Indian Diabetes Market
7.1 Historical Market Trends (2018-2023)
7.2 Market Breakup by Segment (2018-2023)
7.3 Indian Oral Antidiabetics Market
7.3.1 Historical Market Trends (2018-2023)
7.3.2 Market Breakup by Class (2018-2023)
7.3.3 Market Shares of Key Players
7.3.4 Market Outlook (2024-2032)
7.4 Indian Insulin Market
7.4.1 Historical Market Trends (2018-2023)
7.4.2 Market Breakup by Class
7.4.3 Market Shares of Key Players
7.4.4 Market Outlook (2024-2032)
7.5 Market Outlook (2024-2032)
8 Indian Diabetes Diagnostics Market
8.1 Historical Market Trends (2018-2023)
8.2 Market Breakup by Product Type
8.3 Key Players
8.4 Market Outlook (2024-2032)
9 SWOT Analysis
9.1 Overview
9.2 Strengths
9.3 Weaknesses
9.4 Opportunities
9.5 Threats
10 Value Chain Analysis
11 Porter’s Five Forces
11.1 Overview
11.2 Bargaining Power of Buyers
11.3 Bargaining Power of Suppliers
11.4 Degree of Competition
11.5 Threat of New Entrants
11.6 Threat of Substitutes
12 Competitive Landscape
12.1 Market Structure
12.2 Key Player Profiles
List of Figures
Figure 4-1: The Impact of Diabetes on the Human Body
Figure 4-2: Diabetes Complications
Figure 5-1: India: Overweight & Obese Population (in Million), 2018, 2023 & 2032
Figure 5-2: Body Mass Index and Relative Risk of Type-2 Diabetes
Figure 5-3: Global: Breakup of Diabetes Patients by Region (in %), 2023 & 2032
Figure 6-1: India: Total Number of Diabetes Patients (in Million), 2018-2023
Figure 6-2: India: Total Number of Diabetes Patients Forecast (in Million), 2024-2032
Figure 6-3: India (Type1 & Type2): Total Number of Diabetes Patients (in Million), 2018-2023
Figure 6-4: India (Type1 & Type2): Total Number of Diabetes Patients Forecast (in Million), 2024-2032
Figure 6-5: India (Urban & Rural): Total Number of Diabetes Patients (in Million), 2018-2023
Figure 6-6: India (Urban & Rural): Total Number of Diabetes Patients Forecast (in Million), 2024-2032
Figure 6-7: India (Male & Female): Total Number of Diabetes Patients (in Million), 2018-2023
Figure 6-8: India (Male & Female): Total Number of Diabetes Patients Forecast (in Million), 2024-2032
Figure 6-9: India: Total Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79-in Million), 2018-2023
Figure 6-10: India: Total Number of Diabetes Patients Forecast by Age Group (20-39, 40-59, 60-79-in Million), 2024-2032
Figure 6-11: India: Total Diagnosed & Drug Treated Diabetes Population (in Million), 2018-2023
Figure 6-12: India: Total Diagnosed & Drug Treated Diabetes Population Forecast (in Million), 2024-2032
Figure 7-1: India: Diabetes Market (in Billion US$), 2018-2023
Figure 7-2: India: Diabetes Market: Share of Oral Antidiabetics and Insulin (in %), 2018-2023
Figure 7-3: India: Oral Antidiabetics Market (in Million US$), 2018-2023
Figure 7-4: India: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2018-2023
Figure 7-5: India: Oral Antidiabetics Market: Sales Share of Key Players (in %)
Figure 7-6: India: Oral Antidiabetics Market Forecast (in Million US$), 2024-2032
Figure 7-7: India: Insulin Market (in Million US$), 2018-2023
Figure 7-8: India: Insulin Market: Sales Share of Key Classes (in %)
Figure 7-9: India: Insulin Market: Sales Share of Key Players (in %)
Figure 7-10: India: Insulin Market Forecast (in Million US$), 2024-2032
Figure 7-11: India: Diabetes Market Forecast (in Billion US$), 2024-2032
Figure 7-12: India: Diabetes Market Forecast: Share of Oral Antidiabetics and Insulin (in %), 2024-2032
Figure 8-1: India: Glucose Monitoring Market (in Million US$), 2018-2023
Figure 8-2: India: Glucose Monitoring Market: Sales Share by Segment (in %)
Figure 8-3: India: Glucose Monitoring Market: Sales Share of Key Players (in %)
Figure 8-4: India: Glucose Monitoring Market Forecast (in Million US$), 2024-2032
Figure 9-1: India: Diabetes Industry: SWOT Analysis
Figure 10-1: India: Diabetes Industry: Value Chain Analysis
Figure 11-1: India: Diabetes Industry: Porter’s Five Forces Analysis
List of Tables
Table 4-1: India: Diabetes Market: Industry Overview
Table 4-2: Diagnosis of Diabetes
Table 5-1: India: Overweight & Obesity Statistics
Table 5-2: India: Urban & Rural Population Breakup (in Million)
Table 5-3: Global: Diabetes Population Breakup by Country (in 000’s)
Table 5-4: Global: Market Size & Growth Rates of Top Emerging and Developed Diabetes Drug Markets
Table 6-1: India: Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 6-2: India (Type1 & Type2): Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 6-3: India (Urban & Rural): Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 6-4: India (Male & Female): Total Prevalence & Number of Diabetes Patients (in Million), 2018, 2023 & 2032
Table 6-5: India: Total Prevalence & Number of Diabetes Patients by Age Group (20-39, 40-59, 60-79-in Million), 2018, 2023 & 2032
Table 6-6: India: Total Diagnosed & Drug Treated Diabetes Population (in Million), 2018, 2023 & 2032
Table 7-1: India: Diabetes Market: Key Industry Highlights 2023 and 2032